NO970573L - Ylidenforbindelser og deres fremstilling - Google Patents

Ylidenforbindelser og deres fremstilling

Info

Publication number
NO970573L
NO970573L NO970573A NO970573A NO970573L NO 970573 L NO970573 L NO 970573L NO 970573 A NO970573 A NO 970573A NO 970573 A NO970573 A NO 970573A NO 970573 L NO970573 L NO 970573L
Authority
NO
Norway
Prior art keywords
yliden
compounds
preparation
straight
carbon atoms
Prior art date
Application number
NO970573A
Other languages
English (en)
Other versions
NO970573D0 (no
Inventor
Juergen Stoltefuss
Siegfried Goldmann
Alexander Straub
Horst Boeshagen
Martin Bechem
Rainer Gross
Siegbert Hebisch
Joachim Huetter
Howard-Paul Rounding
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO970573L publication Critical patent/NO970573L/no
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO970573D0 publication Critical patent/NO970573D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Ylidenforbindelser med den generelle fonnel (V): der Ri r3 (V) betyr fenyl som eventuelt er substituert med fluor, klor, nitro, trifluormetyl eller med rett eller forgrenet alkyl, eller er substituert med alkoksy med opp til 4 karbonatomer, eller betyr tienyl, og betyr hydrogen eller rett eller forgrenet alkyl med opptil 4 karbonatomer, eller fysiologisk godtagbare salter derav.
NO970573A 1991-05-30 1997-02-07 Ylidenforbindelser og deres fremstilling NO970573D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4117750A DE4117750A1 (de) 1991-05-30 1991-05-30 Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
NO970573L true NO970573L (no) 1992-12-01
NO970573D0 NO970573D0 (no) 1997-02-07

Family

ID=6432811

Family Applications (2)

Application Number Title Priority Date Filing Date
NO92921906A NO921906L (no) 1991-05-30 1992-05-14 Nye 2-amino-5-cyano-1,4-dihydropyridiner, deres fremstilling og anvendelse i legemidler
NO970573A NO970573D0 (no) 1991-05-30 1997-02-07 Ylidenforbindelser og deres fremstilling

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO92921906A NO921906L (no) 1991-05-30 1992-05-14 Nye 2-amino-5-cyano-1,4-dihydropyridiner, deres fremstilling og anvendelse i legemidler

Country Status (22)

Country Link
US (3) US5225558A (no)
EP (1) EP0515940B1 (no)
JP (1) JPH05186459A (no)
KR (1) KR920021530A (no)
AT (1) ATE140455T1 (no)
AU (2) AU656374B2 (no)
CA (1) CA2069860A1 (no)
CZ (1) CZ158692A3 (no)
DE (2) DE4117750A1 (no)
DK (1) DK0515940T3 (no)
ES (1) ES2089286T3 (no)
FI (1) FI922428A7 (no)
GR (1) GR3020575T3 (no)
HU (2) HUT61538A (no)
IE (1) IE921771A1 (no)
IL (3) IL102032A (no)
MX (1) MX9202366A (no)
NO (2) NO921906L (no)
NZ (2) NZ242932A (no)
RU (1) RU2081872C1 (no)
SK (1) SK158692A3 (no)
ZA (1) ZA923935B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683819B1 (fr) * 1991-10-28 1994-02-11 Synthelabo Derives de quinoleine, leur procede de preparation et leur application en therapeutique.
DE69224150T2 (de) * 1991-11-12 1998-10-15 Coatex Sa Mahl- und/oder Dispersionshilfsmittel auf Basis von Polymeren und/oder teilweise durch Magnesium neutralisierten Kopolymeren für wässerige Suspensionen von mineralen Materialien, welche sich eignen für pigmentäre Anwendungen
DE4233586A1 (de) * 1992-10-06 1994-04-07 Bayer Ag 3-Imino-3-alkoxy-propionsäurelactate und deren tautomere Acrylsäurelactate
DE4313696A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-heteroaryl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313695A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-5-cyano-4-chinolyldihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313692A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 3-Chinolyl substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313697A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Chinolyl-dihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313693A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4313691A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2,6-Disubstituierte 4-Chinolyl-dihydropyridine
DE4432378A1 (de) * 1994-09-12 1996-03-14 Bayer Ag Injizierbare liposomale Arzneizubereitungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2359329A (en) * 1943-06-18 1944-10-03 Burroughs Wellcome Co Quinoline substituted dihydropyridines
US4001258A (en) * 1972-03-06 1977-01-04 Bayer Aktiengesellschaft 2-amino-1,4-dihydropyridine derivatives
US3996234A (en) * 1972-04-18 1976-12-07 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
DE2242786A1 (de) * 1972-08-31 1974-03-14 Bayer Ag Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
US3989708A (en) * 1972-08-31 1976-11-02 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2310747A1 (de) * 1973-03-03 1974-09-12 Bayer Ag Verfahren zur herstellung von neuen amino-3,4-dihydropyridinen und ihre verwendung als arzneimittel
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
DE2412750A1 (de) * 1974-03-16 1975-09-18 Bayer Ag Verfahren zur herstellung von 4-amino2,2,6,6-tetramethyl-piperidin
DE2623170C2 (de) * 1976-05-22 1982-03-11 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von α-Cyanzimtaldehyd-Derivaten und 3,4,5-Trimethoxy-α-Cyanzimtaldehyd
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3015219A1 (de) * 1980-04-19 1981-10-22 Bayer Ag, 5090 Leverkusen 6-amino-4,5-dihydropyridin-3-carbonsaeureester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
US5001381A (en) * 1987-12-08 1991-03-19 Akio Takahashi Electro-static motor
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
US5432282A (en) 1995-07-11
SK158692A3 (en) 1995-03-08
IL102032A0 (en) 1992-12-30
KR920021530A (ko) 1992-12-18
CZ158692A3 (en) 1993-07-14
MX9202366A (es) 1992-11-01
US5225558A (en) 1993-07-06
IL102032A (en) 1996-06-18
JPH05186459A (ja) 1993-07-27
HU211579A9 (en) 1995-12-28
FI922428L (fi) 1992-12-01
ATE140455T1 (de) 1996-08-15
RU2081872C1 (ru) 1997-06-20
CA2069860A1 (en) 1992-12-01
FI922428A7 (fi) 1992-12-01
GR3020575T3 (en) 1996-10-31
AU1619995A (en) 1995-08-03
HU9201799D0 (en) 1992-08-28
NO921906L (no) 1992-12-01
ZA923935B (en) 1993-02-24
AU1604592A (en) 1992-12-03
US5380851A (en) 1995-01-10
EP0515940A1 (de) 1992-12-02
AU656374B2 (en) 1995-02-02
NZ264151A (en) 1995-06-27
DK0515940T3 (da) 1996-11-25
IE921771A1 (en) 1992-12-02
HUT61538A (en) 1993-01-28
DE4117750A1 (de) 1992-12-24
NO970573D0 (no) 1997-02-07
DE59206772D1 (de) 1996-08-22
NO921906D0 (no) 1992-05-14
EP0515940B1 (de) 1996-07-17
FI922428A0 (fi) 1992-05-27
ES2089286T3 (es) 1996-10-01
IL116384A0 (en) 1996-03-31
IL116384A (en) 1996-10-16
NZ242932A (en) 1995-06-27

Similar Documents

Publication Publication Date Title
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
YU17092A (sh) Derivati 2,4-diaminohinazolina
BG104248A (en) Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
TR200400185T4 (tr) PDE 5 inhibitörleri olarak, 8-kuinolinkisantin ve 8-izokuinolinkisantin türevleri.
YU74792A (sh) Herbicidi
DK463983A (da) Substituerede 1-hydroxyethyl-triazolyl-derivater, deres fremstilling og anvendelse som plantebeskyttelsesmidler
NO970573L (no) Ylidenforbindelser og deres fremstilling
DK374085A (da) Tryptamin-derivater, deres fremstilling og anvendelse som laegemidler
CY1110284T1 (el) Παραγωγα της 2-αμινο-4-πυριδυλομεθυλο-θειαζολινης και η χρηση τους ως αναστολεις της επαγωγιμης συνθασης νο
DK0436435T3 (da) Phenylethanolaminomethyltetraliner og fremstilling deraf samt farmaceutiske midler indeholdende dem
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
DK209487A (da) Silanderivater, fremgangsmaade til deres fremstilling, midler indeholdende disse forbindelser og deres anvendelse som skadedyrsbekaempelsesmidler
DK0545845T3 (da) Imidazolforbindelser, deres fremstilling og anvendelse som ca-kanal blokkere
DK118083D0 (da) Theophyllinylalkyloxadiazoler eller additionssalte deraf, deres fremstilling og anvendelse som laegemidler
TW355124B (en) Substituted pyrazolylpyrazole derivatives and their use as herbicides
FI945582A0 (fi) Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina
MX9206930A (es) Nuevos compuestos
MY109517A (en) Carboxylic acid derivatives
ES454668A1 (es) Procedimiento para la preparacion de nuevas homoftalimidas.
PT89064A (pt) Processo para a preparacao de compostos piperidinil-1,4-dissubstituidos com accao analgesica e miorrelaxante
DE69806411D1 (de) Neue antiarrythmische verbindungen
CO4940468A1 (es) Nuevos derivados de naftilpiperacina
DK0998464T3 (da) Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser
DK0719271T3 (da) 5-(1-Fluorvinyl)-1H-pyrimidin-2,4-dion-derivater som antineoplastiske midler